drugset / Trial / NCT01383109

Human Mass Balance Study of Pyronaridine

NCT01383109

NaSingle-groupOpen-labelTreatment

Summary

The combination of pyronaridine and artesunate is an antimalarial therapy in development. This mass balance study is intended to determine the rate and extent of excretion of total radioactivity in urine and feces following administration of a single oral micro-dose of 14C-pyronaridine in humans.

Timeline

Start
2011-06
Primary completion
2011-09
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Pyronaridine Unknown 100 ug Oral
Subject Pyronaridine Unknown 720 mg Oral

Indications